Trials / Completed
CompletedNCT02635464
Human Umbilical Cord-derived Mesenchymal Stem Cells With Injectable Collagen Scaffold Transplantation for Chronic Ischemic Cardiomyopathy
The Safety and Efficacy Assessment of Human Umbilical Cord-derived Mesenchymal Stem Cells (hUC-MSCs) With Injectable Collagen Scaffold Transplantation for Chronic Ischemic Cardiomyopathy
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Chinese Academy of Sciences · Other Government
- Sex
- All
- Age
- 35 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to assess the safety and efficacy of allogeneic human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) with injectable collagen scaffold transplanted into patients with chronic ischemic cardiomyopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | hUC-MSCs+Injectable collagen scaffold+CABG | Patients underwent Coronary Artery Bypass Surgery (CABG) with 10\^8 allogeneic human umbilical cord mesenchymal stem cells (hUC-MSCs) in collagen scaffold injecting in the infarct region. |
| BIOLOGICAL | hUC-MSCs+CABG | Patients underwent Coronary Artery Bypass Surgery (CABG) with 10\^8 allogeneic human umbilical cord mesenchymal stem cells (hUC-MSCs) injecting in the infarct region. |
| PROCEDURE | CABG | Patients underwent CABG alone. |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2019-08-01
- Completion
- 2019-08-01
- First posted
- 2015-12-18
- Last updated
- 2020-12-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02635464. Inclusion in this directory is not an endorsement.